EUVIMEDEUVIMED entdecken
Crossref

Ex vivo disease modelling of Rett syndrome: the transcriptomic and metabolomic implications of direct neuronal conversion

Beren Karaosmanoglu iD, Gozde Imren iD, M Samil Ozisin iD, Tuba Reçber, Pelin Ozlem Simsek Kiper, Goknur Haliloglu, Mehmet Alikaşifoğlu, Emirhan Nemutlu, Ekim Z Taskiran iD, Gulen Eda Utine

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09915-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Beren Karaosmanoglu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Medical Genetics, Hacettepe University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Rett Syndrome, Methyl-CpG-Binding Protein 2, Transcriptome, Neurons. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Association for the Prevention of Genetic Diseases, Ankara, Türkiye.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Rett syndrome (RTT) is a rare neurodevelopmental disorder that primarily affects females and is characterized by a period of normal development followed by severe cognitive, motor, and communication impairment. The syndrome is predominantly caused by mutations in the MECP2. This study aimed to use comprehensive multi-omic analysis to identify the molecular and metabolic alterations associated with Rett syndrome. METHODS AND RESULTS: Transcriptomic and metabolomic profiling was performed using neuron-like cells derived from the fibroblasts of 3 Rett syndrome patients with different MECP2 mutations (R168X, P152R, and R133C) and 1 healthy control. Differential gene expression, alternative splicing events, and metabolite changes were analyzed to identify the key pathways and processes affected in patients with Rett syndrome. Transcriptomic analysis showed there was significant down-regulation of genes associated with the extracellular matrix (ECM) and cytoskeletal components, which was particularly notable in patient P3 (R133C mutation), who had non-random X chromosome inactivation. Additionally, significant changes in microtubule-related gene expression and alternative splicing events were observed, especially in patient P2 (P152R mutation). Metabolomic profiling showed that there were alterations in metabolic pathways, particularly up-regulation of ketone body synthesis and degradation pathways, in addition to an increase in free fatty acid levels. Integrated analysis highlighted the interplay between structural gene down-regulation and metabolic shifts, underscoring the adaptive responses to cellular stress in Rett neurons. CONCLUSION: The present findings provide valuable insights into the molecular and metabolic landscape of Rett syndrome, emphasizing the importance of combining omic data to enlighten the molecular pathophysiology of this syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rett SyndromeMethyl-CpG-Binding Protein 2TranscriptomeNeuronsMutationHumansFemaleFibroblastsGene Expression ProfilingMetabolomicsMetabolome

Stichwörter der Autor:innen

Direct conversionMECP2MetabolomicsRett syndrome (RTT)Transcriptomics

Substanzen

Methyl-CpG-Binding Protein 2MECP2 protein, human

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Medical Genetics, Hacettepe University, Ankara, Türkiye.
  • Institute of Health Sciences, Department of Medical and Surgical Research, Hacettepe University, Ankara, Türkiye.
  • Faculty of Pharmacy, Department of Analytical Chemistry, Hacettepe University, Ankara, Türkiye.
  • Faculty of Medicine, Department of Pediatric Genetics, Hacettepe University, Ankara, Türkiye.
  • Faculty of Medicine, Department of Pediatrics, Division of Pediatric Neurology, Hacettepe University, Ankara, Türkiye.
  • Faculty of Medicine, Department of Medical Genetics, Hacettepe University, Ankara, Türkiye. ekimtaskiran@gmail.com.

ORCID-Profile: Beren Karaosmanoglu, Gozde Imren, M Samil Ozisin, Ekim Z Taskiran

Förderung

  • Association for the Prevention of Genetic Diseases, Ankara, Türkiye

Zitieren

APA

Karaosmanoglu, B., Imren, G., Ozisin, M. S., Reçber, T., Simsek Kiper, P. O., Haliloglu, G., Alikaşifoğlu, M., Nemutlu, E., Taskiran, E. Z., & Utine, G. E. (2024). Ex vivo disease modelling of Rett syndrome: the transcriptomic and metabolomic implications of direct neuronal conversion. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09915-6

Vancouver

Karaosmanoglu B, Imren G, Ozisin MS, Reçber T, Simsek Kiper PO, Haliloglu G, et al. Ex vivo disease modelling of Rett syndrome: the transcriptomic and metabolomic implications of direct neuronal conversion. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09915-6

BibTeX
@article{Karaosmanoglu2024,
  author = {Karaosmanoglu, Beren and Imren, Gozde and Ozisin, M Samil and Reçber, Tuba and Simsek Kiper, Pelin Ozlem and Haliloglu, Goknur and Alikaşifoğlu, Mehmet and Nemutlu, Emirhan and Taskiran, Ekim Z and Utine, Gulen Eda},
  title = {Ex vivo disease modelling of Rett syndrome: the transcriptomic and metabolomic implications of direct neuronal conversion},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09915-6}
}
Kostenlos starten →